×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
戻る Agenda
Session 6: Pricing & HTA Challenges for ATMPs
Session Chair(s)
Alexander Natz, JD
Secretary General
European Confederation of Pharmaceutical Entrepreneurs, Belgium
Session 6: Pricing & HTA Challenges for ATMPs
Speaker(s)
HTA methods - implications for ATMPs
Andrew Olaye, PhD, MPharm, MSc
Orchard Therapeutics, United Kingdom
Senior Director, Head of EMEA Market Access
Do we need innovative payment models for ATMP reimbursement in Europe?
Etienne Jousseaume
Novartis, Switzerland
Head Market Access Cell and Gene Europe